Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota-Reference-Cited by-同舟云学术

Vancomycin prevents fermentable fiber-induced liver cancer in mice with dysbiotic gut microbiota

Published:2020-03-30 Issue:4 Volume:11 Page:1077-1091
ISSN:1949-0976
Container-title:Gut Microbes
language:en
Short-container-title:Gut Microbes

Author:

Singh Vishal¹,Yeoh Beng San²³^ORCID,Abokor Ahmed A.²³,Golonka Rachel M.²³,Tian Yuan⁴^ORCID,Patterson Andrew D.⁴^ORCID,Joe Bina²³,Heikenwalder Mathias⁵,Vijay-Kumar Matam²³

Affiliation:

1. Department of Nutritional Sciences, The Pennsylvania State University, University Park, PA, USA

2. Microbiome Consortium, Center for Hypertension and Precision Medicine, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

3. Department of Physiology & Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, OH, USA

4. Department of Veterinary and Biomedical Sciences, The Pennsylvania State University, University Park, PA, USA

5. Division of Chronic Inflammation and Cancer, German Cancer Research Center Heidelberg (DKFZ), Heidelberg, Germany

Funder

Crohn’s and Colitis Foundation of America

H2020 European Research Council

the National Institutes of Health

Publisher

Informa UK Limited

Subject

Infectious Diseases,Microbiology (medical),Gastroenterology,Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/19490976.2020.1743492

Reference37 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Hepatocellular Carcinoma: A Decade of Hospitalizations and Financial Burden in the United States

3. Non-viral causes of hepatocellular carcinoma

4. Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis

5. Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gut Microbiota, Deranged Immunity, and Hepatocellular Carcinoma;Biomedicines;2024-08-07

2. Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies;Cell Biochemistry and Function;2024-07

3. Understanding gut dysbiosis for hepatocellular carcinoma diagnosis and treatment;Trends in Endocrinology & Metabolism;2024-07

4. Nanomaterials modulate tumor-associated macrophages for the treatment of digestive system tumors;Bioactive Materials;2024-06

5. Dietary fiber guar gum-induced shift in gut microbiota metabolism and intestinal immune activity enhances susceptibility to colonic inflammation;Gut Microbes;2024-04-17